Umbilical metastasis (Sister Joseph's nodule) as a first sign of a disseminated ovarian carcinoma: Comparative immunohistochemical analysis of primary tumor and its metastases

International Journal of Gynecological Cancer

Volumn 15, Issue 2, 2005, Pages 377-381

  Brasanac, D ^a   Boricic, I ^a   Todorovic, V ^b   Basta Jovanovic, G ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Catenins; Immunohistochemistry; Ovarian carcinoma; Umbilical metastasis

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CA 125 ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; KI 67 ANTIGEN; PLAKOGLOBIN; PROTEIN MLH1; PROTEIN MSH2; UVOMORULIN;

ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; CHEMICAL LABELING; DISSEMINATED CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; OVARY CARCINOMA; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SISTER JOSEPH NODULE; STAINING; UMBILICUS METASTASIS;

EID: 15444372241     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.15233.x     Document Type: Article

References (22)

1. Krathen RA, Orengo IF, Rosen T. Cutaneous metastasis: a meta-analysis of data. South Med J 2003;96:164-7.
2. Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 patients. J Am Acad Dermatol 1990;22:19-26.
3. Steck WD, Helwig EB. Tumors of the umbilicus. Cancer 1965;18:907-15.
4. Heatley MK, Toner PG. Sister Mary Joseph's nodule: a study of the incidence of biopsied umbilical secondary tumours in a defined population. Br J Surg 1989;76:728-29.
5. Dubreuil A, Dompmartin A, Barjot P, Louvet S, Leroy D. Umbilical metastasis or Sister Mary Joseph's nodule. Int J Dermatol 1998;37:7-13.
6. Sugarbaker PH. Sister Mary Joseph's sign. J Am Coll Surg 2001;193:339-40.
7. Powell FC, Cooper AJ, Massa MC, Goellner JR, Su WPD. Sister Mary Joseph's nodule: a clinical and histologic study. J Am Acad Dermatol 1984;10:610-5.
8. Lecuru F, Darai E, Robin F, Housset M, Durdux C, Taurelle R. Port site metastasis after laparoscopy for gynecological cancer: report of two cases. Acta Obstet Gynecol Scand 2000;79:1021-3.
9. Ohira S, Shiohara S, Itoh K, Ashida T, Fukushima M, Konishi I. Urachal adenocarcinoma metastatic to the ovaries: case report and literature review. Int J Gynecol Pathol 2003;22:189-93.
10. Brabletz T, Jung A, Reu S et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the rumor environment. Proc Natl Acad Sci USA 2001;98:10356-61.
11. Li CC, Xu M, Hirokawa M et al. Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract. Virchows Arch 2002;440:145-54.
12. Oh CW, Penneys N. P27 and Mib1 expression in actinic keratosis, Bowen disease, and squamous cell carcinoma. Am J Dermatopathol 2004;26:22-6.
13. Liu J, Ikeguchi M, Nakamura S, Kaibara N. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival. J Exp Clin Cancer Res 2002;21:65-71.
14. Bukholm IK, Nesland JM, Borresen-Dale AL. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients. J Pathol 2000;190:15-9.
15. Ilyas M Adhesion molecule expression in breast cancer: the phoenix in tumour metastasis? J Pathol 2000;190:3-5.
16. Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chan 2000;275:2727-32.
17. Tan C, Costello P Sanghera J et al. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Oncogene 2001;20:133-40.
18. Zhurinski J, Shtutman M, Ben-Ze'ev A. Plakoglobin and beta-catenin: protein interactions, regulation and biological roles. J Cell Sci 2000;113:3127-39.
19. Mirabelli-Primdahl L, Gryfe R, Kim H et al. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res 1999;59:3346-51.
20. Muc R, Naidoo R. Microsatellite instability in diagnostic pathology. Curr Diagn Pathol 2002;8:318-27.
21. Ichikawa Y, Lemon SJ, Wang S et al. Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members. Cancer Genet Cytogenet 1999;112:2-8.
22. Moreno-Bueno G, Gamallo C, Perez-Gallego L, Calvo de Mora J, Suarez A, Palacios J. Beta-catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Diagn Mol Pathol 2001;10:116-22.